3 High-Risk Biotechs That Could Pop or Drop in 2018 Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three biotech companies that face make-or-break catalysts this year. Source: BioSpace You Might Also Like Strongbridge Biopharma Banks $53 Million Financing From July 16, 2017 Massachusetts Startup Frequency Therapeutics Nabs $32 Million April 10, 2017 Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials March 4, 2018
